Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Betsy B Dokken"'
Autor:
Eliah Aronoff Spencer, Kirstin N. White, Stephanie Habif, Lars Mueller, Harsimran Singh, Betsy B Dokken, Scott Leas, Michelle L. Manning, Eliah S. Aronoff Spencer
Publikováno v:
Diabetes. 70
Incidence of type 1 diabetes (T1D) is increasing in different ethnic groups. Given the rapid evolution of insulin delivery systems, it is important to evaluate their performance in diverse populations. The Control-IQ Observational (CLIO) Study is an
Autor:
Molly McElwee-Malloy, Betsy B Dokken, Kirstin N. White, Lars Mueller, Alexandra Constantin, Stephanie Habif, Harsimran Singh, Jordan E. Pinsker
Publikováno v:
Diabetes. 70
The Control-IQ technology Observational (CLIO) study prospectively follows a large, diverse cohort with type 1 diabetes with varied insulin use and baseline glycemic control. To study insulin use on the t:slim X2 pump with Control-IQ technology, we c
Autor:
Melissa J, Schoelwer, Lauren G, Kanapka, R Paul, Wadwa, Marc D, Breton, Katrina J, Ruedy, Laya, Ekhlaspour, Gregory P, Forlenza, Erin C, Cobry, Laurel H, Messer, Eda, Cengiz, Emily, Jost, Lori, Carria, Emma, Emory, Liana J, Hsu, Stuart A, Weinzimer, Bruce A, Buckingham, Rayhan A, Lal, Mary Clancy, Oliveri, Craig C, Kollman, Betsy B, Dokken, Daniel R, Cherñavvsky, Roy W, Beck, Mark D, DeBoer, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased time-in-range (TIR) 70–180 mg/dL. However, clinical predictors of TIR in user
Autor:
the iDCL Trial Research Group, Roy W. Beck, Daniel Cherñavvsky, Betsy B. Dokken, Craig Kollman, Mary Oliveri, Bruce A. Buckingham, Mark D. DeBoer, Stuart A. Weinzimer, Liana J. Hsu, Emma Emory, Lori Carria, Emily Jost, Melissa J. Schoelwer, Eda Cengiz, Gregory P. Forlenza, Laya Ekhlaspour, Katrina J. Ruedy, Marc D. Breton, R. Paul Wadwa, Lauren G. Kanapka
Objective: To further evaluate the safety and efficacy of the Control-IQ closed loop control (CLC) system in children with type 1 diabetes. Research Design and Methods: Following a 16-week randomized clinical trial (RCT) comparing CLC with sensor aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5edbd08406fd9aaa7a8035cc8b6acc
https://doi.org/10.2337/figshare.13260212.v1
https://doi.org/10.2337/figshare.13260212.v1
Autor:
Betsy B. Dokken, Nicole Ciffone
Publikováno v:
Journal of the American Association of Nurse Practitioners. 29:224-235
Background Recent updates to clinical guidelines and pharmacological indications have added to the complexity of acute coronary syndrome (ACS) management. Advanced practice nurses working with ACS patients need clear and up-to-date information to opt
Autor:
Betsy B. Dokken, Karl B. Kern, Charles V Piermarini, Jonida Krate, Mary K. Teachey, A. M. Asghar, Brian D Heller, Michael Gura, Ronald W. Hilwig, Lauren Querin, Christian Dameff, J. L. Mitchell
Publikováno v:
American journal of physiology. Heart and circulatory physiology. 315(6)
Autor:
Tatiana Marcal, Zoey Li, R. Paul Wadwa, Lori R. Carria, Betsy B Dokken, Roy Beck, Mei Mei Church, Stuart A. Weinzimer, William J. Woodall, Camille C. Andre, Bruce A. Buckingham, Vance Swanson, Craig Kollman, Jordan E. Pinsker, Gregory P. Forlenza, Emily Jost, Eda Cengiz, Laya Ekhlaspour, John W. Lum
Publikováno v:
Diabetes. 67
Background: Our research study group recently evaluated a PLGS system embedded on the Tandem t:slim X2 with Basal-IQ insulin pump. The system was designed to work "in the background" without alarms when suspending and restarting insulin delivery. Sys
Publikováno v:
Academic Emergency Medicine. 22:197-203
Objectives Nitric oxide (NO) is a critical regulator of vascular tone and signal transduction in the cardiovascular system. NO is synthesized by three unique enzymes (nitric oxide synthases [NOS]): endothelial and neuronal NOS, both constitutively ex
Autor:
Charles V Piermarini, Betsy B. Dokken, Aeen M Ashgar, Karl B. Kern, Brian D Heller, Jonida Krate, Ronald W. Hilwig, Lauren Querin, Mary K. Teachey, Christian Dameff, Jennifer L Mitchell, Michael Gura
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 304:H538-H546
Glucagon-like peptide-1 (GLP-1) has protective effects in the heart. We hypothesized that GLP-1 would mitigate coronary microvascular and left ventricular (LV) dysfunction if administered after cardiac arrest and resuscitation (CAR). Eighteen swine w
Autor:
Betsy B. Dokken
Publikováno v:
Diabetes Spectrum. 25:29-36
Type 2 diabetes is a complex and progressive disease that affects 8.3% of the U.S. population. Despite the availability of numerous treatment options for type 2 diabetes, the proportion of patients achieving glycemic goals is unacceptably low; theref